Patent details

301112 Product Name: COVID-19-vaccin (ChAdOx1-S [recombinant])

The time of generation of the report may vary depending on the number of the selected files and the pages of each file. If the generation of the consolidated PDF file takes long, you may reduce the number of selected files and proceed with the generation of the PDF in batches.
You have not selected any documents

Basic Information

Publication number:
301112
Type:
Certificate
SPC Type:
Medical
Basic Patent Number:
EP2714916
Status:
Application Pending
Application number:
301112
Procedural language:
Dutch
First Applicant Residence Country:
United Kingdom (GB)

Marketing Authorization

1

Marketing Authorization Number:
EU/1/21/1529
Marketing Authorization Type:
EEA
Marketing Authorization Date:
29/01/2021
Marketing Authorization Country:
European Union (EU)

2

Marketing Authorization Number:
PLGB 17901/0355
Marketing Authorization Type:
EEA
Marketing Authorization Date:
29/12/2020
Marketing Authorization Country:
United Kingdom (GB)

Dates

Filing date:
25/06/2021
First Marketing Authorization date:
29/12/2020
Grant date:
Activation date:
Lapsed By Non Payment Annual Fee Date:
Renunciation Date:
NullificationDate:
Registration date:
28/06/2021
SPC/SPC Extension Expiration Date:
Lapsed By Expiration Date:
Withdrawal date:
Revocation Date:
Invalidity Date:
Withdrawal Market Authorization Date:
Refusal Date:

Applicant/holder

From:
25/06/2021
 
 

 

Name:
Oxford University Innovation Limited
Address:
Buxton Court 3 West Way, Botley Oxford OX2 0JB, United Kingdom (GB)

Agent

Name:
ir. M.F.J.M. Ketelaars c.s.
From:
25/06/2021
Address:
NLO Postbus 29720, 2502 LS, Den Haag, Netherlands (NL)
To:

Publication

Bulletin

Bulletin Heading:
SPC
Journal edition number:
26/21
Publication date:
30/06/2021
Description:
Applications and granted Supplementary Protection Certificates (or the extensions of the Supplementary Protection Certificates)
Filing date Document type Document Description Number of pages File Type
28/06/2021 Outgoing Correspondence Confirmation receipt request 1 PDF /3/3/4/7/9/0800697433/docs/301112_6_419683l174.pdf
25/06/2021 Application Form First filed application form 2 PDF /3/3/4/7/9/0800697433/docs/301112_0_applicationform20210628084021735.pdf
25/06/2021 SPC Documents Annex SPC 11 PDF /3/3/4/7/9/0800697433/docs/301112_1_supplprotectioncertificate20210628085940976.pdf
25/06/2021 SPC Documents Summary of the characteristics of the product 11 PDF /3/3/4/7/9/0800697433/docs/301112_2_supplprotectioncertificate20210628085106007.pdf
25/06/2021 SPC Documents Annex SPC 57 PDF /3/3/4/7/9/0800697433/docs/301112_3_supplprotectioncertificate20210628085941234.pdf
25/06/2021 SPC Documents Marketing Authorization SPC 3 PDF /3/3/4/7/9/0800697433/docs/301112_4_supplprotectioncertificate20210628084608761.pdf
25/06/2021 SPC Documents Annex SPC 1 PDF /3/3/4/7/9/0800697433/docs/301112_5_supplprotectioncertificate20210628084652748.pdf